Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan N Jackson

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Molecular Cell|June 2, 2015
A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune ResponsesRyan N Jackson, Blake Wiedenheft
RNA Biology|September 22, 2012
Ski2-like RNA helicase structures: common themes and complex assembliesSean J Johnson, Ryan N Jackson
Current Opinion in Structural Biology|February 1, 2014
Fitting CRISPR-associated Cas3 into the helicase family treeRyan N Jackson, Matthew Lavin, Joshua Carter, et al.
Nature Reviews. Microbiology|June 10, 2014
Unravelling the structural and mechanistic basis of CRISPR-Cas systemsJohn van der Oost, Edze R Westra, Ryan N Jackson, et al.
Current Opinion in Microbiology|June 25, 2017
Conformational regulation of CRISPR-associated nucleasesRyan N Jackson, Paul Bg van Erp, Samuel H Sternberg, et al.
Methods in Enzymology|March 22, 2025
Purification and in vivo, cell-free, and in vitro characterization of CRISPR-Cas12a2Friso T Schut, Thomson Hallmark, Oleg Dmytrenko, et al.
Methods in Enzymology|March 22, 2025
Determining the biochemical function of type IV CRISPR ribonucleoprotein complexes and accessory proteinsAndrew A Williams, Olivine Redman, Hannah Domgaard, et al.
Micropublication Biology|June 24, 2024
The N-terminal domain of Type IV-A1 CRISPR-associated DinG is vulnerable to proteolysisThomson Hallmark, Andrew A Williams, Olivine Redman, et al.
Nature Protocols|July 31, 2015
X-ray structure determination using low-resolution electron microscopy maps for molecular replacementRyan N Jackson, Airlie J McCoy, Thomas C Terwilliger, et al.
Nucleic Acids Research|July 3, 2023
CasDinG is a 5'-3' dsDNA and RNA/DNA helicase with three accessory domains essential for type IV CRISPR immunityHannah Domgaard, Christian Cahoon, Matthew J Armbrust, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Molecular Cell|June 2, 2015
A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune ResponsesRyan N Jackson, Blake Wiedenheft
RNA Biology|September 22, 2012
Ski2-like RNA helicase structures: common themes and complex assembliesSean J Johnson, Ryan N Jackson
Current Opinion in Structural Biology|February 1, 2014
Fitting CRISPR-associated Cas3 into the helicase family treeRyan N Jackson, Matthew Lavin, Joshua Carter, et al.
Nature Reviews. Microbiology|June 10, 2014
Unravelling the structural and mechanistic basis of CRISPR-Cas systemsJohn van der Oost, Edze R Westra, Ryan N Jackson, et al.
Current Opinion in Microbiology|June 25, 2017
Conformational regulation of CRISPR-associated nucleasesRyan N Jackson, Paul Bg van Erp, Samuel H Sternberg, et al.
Methods in Enzymology|March 22, 2025
Purification and in vivo, cell-free, and in vitro characterization of CRISPR-Cas12a2Friso T Schut, Thomson Hallmark, Oleg Dmytrenko, et al.
Methods in Enzymology|March 22, 2025
Determining the biochemical function of type IV CRISPR ribonucleoprotein complexes and accessory proteinsAndrew A Williams, Olivine Redman, Hannah Domgaard, et al.
Micropublication Biology|June 24, 2024
The N-terminal domain of Type IV-A1 CRISPR-associated DinG is vulnerable to proteolysisThomson Hallmark, Andrew A Williams, Olivine Redman, et al.
Nature Protocols|July 31, 2015
X-ray structure determination using low-resolution electron microscopy maps for molecular replacementRyan N Jackson, Airlie J McCoy, Thomas C Terwilliger, et al.
Nucleic Acids Research|July 3, 2023
CasDinG is a 5'-3' dsDNA and RNA/DNA helicase with three accessory domains essential for type IV CRISPR immunityHannah Domgaard, Christian Cahoon, Matthew J Armbrust, et al.
Pageof 4